Efficacy and safety results from the randomized controlled c…
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis %28CHAMPION%29.
Article, Chapter
Authors:
J.H.
Publication:
Volume:158,
Page(s):558
Published:
2008
We were unable to find direct full text links for this item.